Product
Omegaven
3 clinical trials
6 indications
Indication
Essential Fatty Acid DeficiencyIndication
MalnutritionIndication
Pediatric Acute Lymphoblastic LeukemiaIndication
Hematopoietic Stem Cell TransplantationClinical trial
Title: A Single-arm, Open-label, Prospective, Multicenter Safety Study to Evaluate the Occurrence of Essential Fatty Acid Deficiency (EFAD) in Pediatric Patients With Parenteral Nutrition-associated Cholestasis (PNAC) Who Require More Than Eight Weeks of Omegaven TreatmentStatus: Not yet recruiting, Estimated PCD: 2026-03-01
Clinical trial
Compassionate Use of an Intravenous Fish Oil Lipid Emulsion (Omegaven®) for the Treatment of Intestinal Failure Associated Liver Disease in ChildrenStatus:
Clinical trial
Safety and Tolerability of Intravenous Fish Oil Lipid Emulsion in Children Undergoing Hematopoietic Cell TransplantationStatus: Completed, Estimated PCD: 2023-05-18